Cargando…

Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

The substantial biological heterogeneity of metastatic prostate cancer has hindered the development of personalized therapeutic approaches. Therefore, it is difficult to predict the course of metastatic hormone-sensitive prostate cancer (mHSPC), with some men remaining on first-line androgen depriva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reichert, Zachery R., Kasputis, Tadas, Nallandhighal, Srinivas, Abusamra, Sophia M., Kasputis, Amy, Haruray, Saloni, Wang, Yugang, Williams, Shamara, Singhal, Udit, Alva, Ajjai, Cackowski, Frank C., Caram, Megan E. V., Palmbos, Phillip L., Yentz, Sarah E., Smith, David C., Alumkal, Joshi J., Morgan, Todd M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744626/ https://www.ncbi.nlm.nih.gov/pubmed/35008431 http://dx.doi.org/10.3390/ijms23010004

Ejemplares similares

Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19
por: Gould, A., et al.
Publicado: (2023)

Comparing costs and health care resource utilization between nmHSPC and mHSPC patients: a retrospective claims analysis
por: Ko, Gilbert Chao, et al.
Publicado: (2022)

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting
por: Ng, Kenrick, et al.
Publicado: (2020)

The role of surface chemistry-induced cell characteristics on nonviral gene delivery to mouse fibroblasts
por: Kasputis, Tadas, et al.
Publicado: (2012)

Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored?
por: Thomas, Christian, et al.
Publicado: (2021)

Estimating utilities/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events
por: Hall, F., et al.
Publicado: (2019)

(225)Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings
por: Sathekge, Mike, et al.
Publicado: (2023)

Qualitative and Quantitative Assessment of Patient and Carer Experience of Chemotherapy (Docetaxel) in Combination with Androgen Deprivation Therapy (ADT) for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
por: Ito, Tetsuro, et al.
Publicado: (2018)

Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion()
por: Wang, Yugang, et al.
Publicado: (2020)

SYSTEMIC TRIPLE THERAPY IN METASTATIC HORMONE SENSITIVE PROSTATE CANCER (MHSPC)
por: Omrčen, Tomislav
Publicado: (2022)

Re-examining HSPC1 inhibitors
por: Lee, Sheah Lin, et al.
Publicado: (2017)

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
por: Zaslavsky, Alexander B., et al.
Publicado: (2020)

HSPC300 and its role in neuronal connectivity
por: Qurashi, Abrar, et al.
Publicado: (2007)

Flow Dynamics and HSPC Homing in Bone Marrow Microvessels
por: Bixel, M. Gabriele, et al.
Publicado: (2017)

Geographic clonal tracking in macaques provides insights into HSPC migration and differentiation
por: Wu, Chuanfeng, et al.
Publicado: (2018)

Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study
por: Vidal Insua, Yolanda, et al.
Publicado: (2017)

Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer
por: Xu, Ying, et al.
Publicado: (2023)

HSPC117 Is Regulated by Epigenetic Modification and Is Involved in the Migration of JEG-3 Cells
por: Ma, Hong, et al.
Publicado: (2014)

Promoter-Associated RNAs Regulate HSPC152 Gene Expression in Malignant Melanoma
por: Bonen, Hamutal, et al.
Publicado: (2016)

Bone marrow niche-mimetics modulate HSPC function via integrin signaling
por: Kräter, Martin, et al.
Publicado: (2017)

Mechanical Properties Determination of DMPC, DPPC, DSPC, and HSPC Solid-Ordered Bilayers
por: Drabik, Dominik, et al.
Publicado: (2020)

Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs
por: Allen, Joshua E., et al.
Publicado: (2013)

Angiopoietin-like proteins stimulate HSPC development through interaction with notch receptor signaling
por: Lin, Michelle I, et al.
Publicado: (2015)

Defective AMPK regulation of cholesterol metabolism accelerates atherosclerosis by promoting HSPC mobilization and myelopoiesis
por: Lee, Man K.S., et al.
Publicado: (2022)

ERBB signaling in CTCs of ovarian cancer and glioblastoma
por: Geethadevi, Anjali, et al.
Publicado: (2017)

CTCs 2020: Great Expectations or Unreasonable Dreams
por: Rossi, Elisabetta, et al.
Publicado: (2019)

Evaluation of α-tubulin, detyrosinated α-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements
por: Kallergi, G., et al.
Publicado: (2018)

Loss of Dictyostelium HSPC300 causes a scar-like phenotype and loss of SCAR protein
por: Pollitt, Alice Y, et al.
Publicado: (2009)

The Molecular and Functional Interaction between ICln and HSPC038 Proteins Modulates the Regulation of Cell Volume
por: Dossena, Silvia, et al.
Publicado: (2011)

Expression and subcellular localization of HSPC117 in min pig tissues and the PK15 cell line
por: Ma, Hong, et al.
Publicado: (2019)

TGFβ Inhibitor A83-01 Enhances Murine HSPC Expansion for Gene Therapy
por: Fleischauer, Jenni, et al.
Publicado: (2023)

EMT, CTCs and CSCs in tumor relapse and drug-resistance
por: Mitra, Abhisek, et al.
Publicado: (2015)

CTCs Expression Profiling for Advanced Breast Cancer Monitoring
por: Pereira-Veiga, Thais, et al.
Publicado: (2019)

Potential Use of CTCs as Biomarkers in Renal Cancer Patients
por: Bialek, Joanna, et al.
Publicado: (2022)

Combinatorial Power of cfDNA, CTCs and EVs in Oncology
por: Keup, Corinna, et al.
Publicado: (2022)

Ex vivo expansion of circulating tumour cells (CTCs)
por: Mohamed, Bashir M., et al.
Publicado: (2023)

Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions
por: Schochter, Fabienne, et al.
Publicado: (2019)

Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients
por: Huang, Shanshan, et al.
Publicado: (2017)

Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source
por: Hess, Nicholas J., et al.
Publicado: (2020)

Using a new HSPC senescence model in vitro to explore the mechanism of cellular memory in aging HSPCs
por: Dong, Yongpin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_31evtbsss4pnrg6a8jaherc9hd